TaiwanJ Pharmaceuticals Co., Ltd. (6549) Stock Statistics & Valuation Metrics
Total Valuation
TaiwanJ Pharmaceuticals Co., Ltd. has a market cap or net worth of TWD 483.94M. The enterprise value is ―.
- Market Cap
- TWD 483.94M
- Enterprise Value
- ―
Share Statistics
TaiwanJ Pharmaceuticals Co., Ltd. has 80,122,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 80,122,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TaiwanJ Pharmaceuticals Co., Ltd.’s return on equity (ROE) is -0.34 and return on invested capital (ROIC) is -34.67%.
- Return on Equity (ROE)
- -0.34
- Return on Assets (ROA)
- -0.32
- Return on Invested Capital (ROIC)
- -34.67%
- Return on Capital Employed (ROCE)
- -0.35
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.87M
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of TaiwanJ Pharmaceuticals Co., Ltd. is -24.81. TaiwanJ Pharmaceuticals Co., Ltd.’s PEG ratio is -0.83.
- PE Ratio
- -24.81
- PS Ratio
- 0.00
- PB Ratio
- 7.23
- Price to FCF
- -25.78
- Price to Operating Cash Flow
- -25.78
- PEG Ratio
- -0.83
Income Statement
In the last 12 months, TaiwanJ Pharmaceuticals Co., Ltd. had revenue of 0 and earned -24.34M in profits. Earnings per share was -0.30.
- Revenue
- 0
- Gross Profit
- -1.61M
- Operating Income
- -25.21M
- Pretax Income
- -24.34M
- Net Income
- -24.34M
- EBITDA
- -23.61M
- Earnings Per Share (EPS)
- -0.30
Cash Flow
In the last 12 months, operating cash flow was -18.03M and capital expenditures 0, giving a free cash flow of -18.03M billion.
- Operating Cash Flow
- -18.03M
- Free Cash Flow
- -18.03M
- Free Cash Flow per Share
- -0.23
Dividends & Yields
TaiwanJ Pharmaceuticals Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.73%
- Earnings Yield
- -3.79%
Stock Price Statistics
- Beta
- 0.44
- 52-Week Price Change
- -23.16%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 29.08
- Average Volume (3m)
- 68.18K
Financial Position
TaiwanJ Pharmaceuticals Co., Ltd. as a current ratio of 13.81, with Debt / Equity ratio of 2.52%
- Current Ratio
- 13.81
- Quick Ratio
- 13.81
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.80
- Interest Coverage Ratio
- -484.85
Taxes
In the past 12 months, TaiwanJ Pharmaceuticals Co., Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
TaiwanJ Pharmaceuticals Co., Ltd. EV to EBITDA ratio is -21.62, with an EV/FCF ratio of -23.62.
- EV to Sales
- 0.00
- EV to EBITDA
- -21.62
- EV to Free Cash Flow
- -23.62
- EV to Operating Cash Flow
- -23.62
Balance Sheet
TaiwanJ Pharmaceuticals Co., Ltd. has TWD 60.17M in cash and marketable securities with TWD 2.07M in debt, giving a net cash position of TWD 58.10M billion.
- Cash & Marketable Securities
- TWD 60.17M
- Total Debt
- TWD 2.07M
- Net Cash
- TWD 58.10M
- Net Cash Per Share
- TWD 0.73
- Tangible Book Value Per Share
- TWD 0.80
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for TaiwanJ Pharmaceuticals Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 28.77%
